Melissa A Walker, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondrial Diseases | 6 | 2023 | 342 | 1.930 |
Why?
|
| Leigh Disease | 3 | 2023 | 89 | 1.310 |
Why?
|
| MELAS Syndrome | 3 | 2024 | 56 | 1.230 |
Why?
|
| Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2024 | 15 | 0.950 |
Why?
|
| Puberty, Precocious | 1 | 2023 | 163 | 0.800 |
Why?
|
| Adrenal Insufficiency | 1 | 2023 | 194 | 0.770 |
Why?
|
| Hyperthyroidism | 1 | 2023 | 294 | 0.770 |
Why?
|
| Endocrine System Diseases | 1 | 2023 | 249 | 0.750 |
Why?
|
| Nervous System | 1 | 2023 | 545 | 0.700 |
Why?
|
| DNA, Mitochondrial | 3 | 2024 | 865 | 0.670 |
Why?
|
| Genes, Mitochondrial | 1 | 2019 | 58 | 0.650 |
Why?
|
| Disease | 1 | 2023 | 670 | 0.600 |
Why?
|
| Spinal Cord Diseases | 1 | 2021 | 291 | 0.600 |
Why?
|
| Cerebellar Ataxia | 1 | 2019 | 150 | 0.590 |
Why?
|
| Nucleotidyltransferases | 1 | 2019 | 242 | 0.560 |
Why?
|
| Genes, Recessive | 1 | 2019 | 622 | 0.540 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2016 | 15 | 0.540 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2016 | 85 | 0.500 |
Why?
|
| Mitochondrial Proteins | 2 | 2021 | 974 | 0.470 |
Why?
|
| Mutation | 9 | 2022 | 30002 | 0.450 |
Why?
|
| Lymphocyte Activation | 1 | 2024 | 5478 | 0.420 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 1085 | 0.400 |
Why?
|
| Heterozygote | 2 | 2020 | 2778 | 0.350 |
Why?
|
| Phenotype | 8 | 2022 | 16575 | 0.340 |
Why?
|
| Polymorphism, Genetic | 1 | 2020 | 4243 | 0.340 |
Why?
|
| Mitochondria | 5 | 2023 | 3620 | 0.340 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 724 | 0.330 |
Why?
|
| Immune System | 1 | 2014 | 792 | 0.320 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2014 | 619 | 0.310 |
Why?
|
| Microcephaly | 3 | 2022 | 425 | 0.300 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5842 | 0.250 |
Why?
|
| RNA, Transfer, Leu | 1 | 2024 | 13 | 0.230 |
Why?
|
| Chondroitinsulfatases | 1 | 2023 | 16 | 0.220 |
Why?
|
| Nervous System Malformations | 2 | 2022 | 244 | 0.210 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10203 | 0.210 |
Why?
|
| Phosphatidylinositols | 1 | 2023 | 281 | 0.200 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2022 | 53 | 0.200 |
Why?
|
| Aphasia | 1 | 2024 | 192 | 0.200 |
Why?
|
| Immunity, Innate | 1 | 2014 | 3044 | 0.200 |
Why?
|
| Confusion | 1 | 2024 | 278 | 0.190 |
Why?
|
| Antiporters | 2 | 2023 | 276 | 0.190 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2021 | 85 | 0.180 |
Why?
|
| Genome, Mitochondrial | 1 | 2020 | 67 | 0.170 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2022 | 284 | 0.170 |
Why?
|
| Drosophila melanogaster | 2 | 2023 | 1710 | 0.170 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 158 | 0.160 |
Why?
|
| Carotid Artery, Internal | 1 | 2021 | 445 | 0.160 |
Why?
|
| Databases, Protein | 1 | 2021 | 386 | 0.160 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 2018 | 27 | 0.160 |
Why?
|
| Amino Acid Transport Systems, Acidic | 1 | 2018 | 30 | 0.150 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 518 | 0.150 |
Why?
|
| Moyamoya Disease | 1 | 2021 | 265 | 0.150 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2018 | 42 | 0.150 |
Why?
|
| Head | 1 | 2024 | 922 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 319 | 0.150 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2018 | 84 | 0.150 |
Why?
|
| Lipomatosis | 1 | 2018 | 112 | 0.150 |
Why?
|
| Rare Diseases | 1 | 2023 | 624 | 0.140 |
Why?
|
| Psychomotor Disorders | 1 | 2018 | 149 | 0.140 |
Why?
|
| Spasms, Infantile | 1 | 2021 | 298 | 0.140 |
Why?
|
| Prenatal Diagnosis | 1 | 2024 | 1267 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 257 | 0.140 |
Why?
|
| Ataxia | 2 | 2020 | 305 | 0.140 |
Why?
|
| Bone Marrow Diseases | 1 | 2018 | 233 | 0.130 |
Why?
|
| Humans | 31 | 2024 | 761208 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2024 | 1757 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 1 | 2020 | 833 | 0.130 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2022 | 781 | 0.130 |
Why?
|
| beta Catenin | 1 | 2020 | 1042 | 0.130 |
Why?
|
| Growth Disorders | 1 | 2020 | 634 | 0.120 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 517 | 0.120 |
Why?
|
| Homozygote | 1 | 2019 | 1775 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2022 | 1301 | 0.110 |
Why?
|
| Central Nervous System | 1 | 2021 | 1333 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1838 | 0.110 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 2731 | 0.110 |
Why?
|
| Female | 18 | 2024 | 392544 | 0.110 |
Why?
|
| Brain Diseases | 1 | 2022 | 1545 | 0.110 |
Why?
|
| Ubiquinone | 1 | 2014 | 183 | 0.110 |
Why?
|
| Histones | 1 | 2023 | 2570 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 17897 | 0.100 |
Why?
|
| Models, Immunological | 1 | 2014 | 515 | 0.100 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 1510 | 0.100 |
Why?
|
| Infant, Newborn | 3 | 2024 | 26199 | 0.100 |
Why?
|
| Mutation, Missense | 4 | 2022 | 2567 | 0.100 |
Why?
|
| Cerebellum | 1 | 2019 | 1501 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 2244 | 0.090 |
Why?
|
| Muscle Weakness | 1 | 2014 | 412 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 4372 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1838 | 0.090 |
Why?
|
| Proteome | 1 | 2021 | 1856 | 0.090 |
Why?
|
| Child, Preschool | 6 | 2021 | 42224 | 0.090 |
Why?
|
| Infarction | 1 | 2011 | 248 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 1663 | 0.080 |
Why?
|
| Adult | 8 | 2024 | 221119 | 0.080 |
Why?
|
| Muscle Hypotonia | 2 | 2021 | 161 | 0.080 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2011 | 180 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2022 | 1989 | 0.080 |
Why?
|
| Immunity | 1 | 2014 | 996 | 0.080 |
Why?
|
| Child | 9 | 2023 | 80152 | 0.080 |
Why?
|
| Thrombophilia | 1 | 2011 | 306 | 0.080 |
Why?
|
| Alleles | 1 | 2019 | 6857 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2021 | 3537 | 0.070 |
Why?
|
| Recurrence | 2 | 2024 | 8457 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1791 | 0.070 |
Why?
|
| Cadherins | 1 | 2011 | 902 | 0.070 |
Why?
|
| Epilepsy | 2 | 2021 | 3304 | 0.070 |
Why?
|
| Syndrome | 2 | 2023 | 3271 | 0.070 |
Why?
|
| Male | 11 | 2024 | 360693 | 0.060 |
Why?
|
| Drosophila | 2 | 2023 | 1495 | 0.060 |
Why?
|
| Adolescent | 7 | 2021 | 88298 | 0.060 |
Why?
|
| Genotype | 1 | 2019 | 12985 | 0.060 |
Why?
|
| Pregnancy | 2 | 2024 | 29893 | 0.060 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2023 | 17 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2756 | 0.050 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2023 | 201 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2011 | 1696 | 0.050 |
Why?
|
| Histiocytosis | 1 | 2022 | 39 | 0.050 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2022 | 99 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18220 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2004 | 396 | 0.050 |
Why?
|
| Placenta | 1 | 2011 | 1711 | 0.050 |
Why?
|
| Proteins | 3 | 2022 | 5993 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2023 | 436 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2023 | 411 | 0.050 |
Why?
|
| Animals | 7 | 2023 | 168079 | 0.050 |
Why?
|
| Hydroxybutyrates | 1 | 2021 | 76 | 0.050 |
Why?
|
| Middle Aged | 6 | 2024 | 220853 | 0.040 |
Why?
|
| Speech Disorders | 1 | 2021 | 180 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2020 | 12099 | 0.040 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2020 | 44 | 0.040 |
Why?
|
| Infant | 3 | 2020 | 36169 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2011 | 2923 | 0.040 |
Why?
|
| Reflex, Abnormal | 1 | 2020 | 83 | 0.040 |
Why?
|
| Contracture | 1 | 2022 | 235 | 0.040 |
Why?
|
| Mitochondrial Membranes | 1 | 2021 | 176 | 0.040 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2021 | 197 | 0.040 |
Why?
|
| Ribonucleoprotein, U5 Small Nuclear | 1 | 2018 | 7 | 0.040 |
Why?
|
| Cerebral Revascularization | 1 | 2021 | 259 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2023 | 1867 | 0.040 |
Why?
|
| Peptide Elongation Factors | 1 | 2018 | 60 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2023 | 597 | 0.040 |
Why?
|
| Calcium | 1 | 2011 | 5719 | 0.040 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2018 | 26 | 0.040 |
Why?
|
| Folate Receptor 1 | 1 | 2018 | 40 | 0.040 |
Why?
|
| Alanine | 1 | 2021 | 608 | 0.040 |
Why?
|
| Tetrahydrofolates | 1 | 2018 | 58 | 0.040 |
Why?
|
| Facial Paralysis | 1 | 2021 | 346 | 0.040 |
Why?
|
| Mice | 2 | 2021 | 81326 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 59221 | 0.040 |
Why?
|
| Osteochondrodysplasias | 1 | 2018 | 182 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2022 | 1130 | 0.040 |
Why?
|
| Prevalence | 1 | 2014 | 15721 | 0.030 |
Why?
|
| Dystonia | 1 | 2020 | 370 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2022 | 7851 | 0.030 |
Why?
|
| Germ Cells | 1 | 2020 | 632 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 36415 | 0.030 |
Why?
|
| Actins | 1 | 2023 | 2046 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2023 | 1356 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2021 | 1139 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 603 | 0.030 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2014 | 80 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 2189 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 2014 | 312 | 0.030 |
Why?
|
| Age of Onset | 1 | 2020 | 3307 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2021 | 2329 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39126 | 0.030 |
Why?
|
| Adhesiveness | 1 | 2011 | 52 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4243 | 0.020 |
Why?
|
| Zebrafish | 1 | 2023 | 3000 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 680 | 0.020 |
Why?
|
| Pregnancy, High-Risk | 1 | 2011 | 121 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2011 | 261 | 0.020 |
Why?
|
| Aged | 3 | 2023 | 169288 | 0.020 |
Why?
|
| Retina | 1 | 2020 | 2655 | 0.020 |
Why?
|
| Brain | 3 | 2021 | 27092 | 0.020 |
Why?
|
| Parents | 1 | 2023 | 3564 | 0.020 |
Why?
|
| Internet | 1 | 2021 | 3096 | 0.020 |
Why?
|
| Maternal Age | 1 | 2011 | 809 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2014 | 80674 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 2175 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 1978 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2023 | 58952 | 0.020 |
Why?
|
| Software | 1 | 2021 | 4431 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2011 | 974 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 12976 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3418 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3778 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2021 | 41496 | 0.010 |
Why?
|
| Kinetics | 1 | 2011 | 6312 | 0.010 |
Why?
|
| DNA Gyrase | 1 | 2004 | 85 | 0.010 |
Why?
|
| Crystallization | 1 | 2004 | 527 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2018 | 6567 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15841 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4537 | 0.010 |
Why?
|
| Gestational Age | 1 | 2011 | 3580 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5406 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2004 | 422 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 13402 | 0.010 |
Why?
|
| Protein Binding | 1 | 2011 | 9297 | 0.010 |
Why?
|
| Dogs | 1 | 2004 | 3832 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 17598 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 1988 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 3264 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2004 | 3933 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 21365 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 29687 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 24021 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 64681 | 0.000 |
Why?
|